Methacrylic Acid

Methacrylic Acid

SCHEMBL346724

C=C(C)C(=O)O.C=C(C)C(=O)O.CCC

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.44
FFAR3 O14843 3/20 0.41
ALDH1A1 P00352 3/20 0.41
LCK P06239 1/20 0.40
FYN P06241 1/20 0.40
THRB P10828 1/20 0.37
TSHR P16473 3/20 0.36
TGFBR1 P36897 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
TET2 Q6N021 1/20 0.35
HSD17B10 Q99714 2/20 0.33
LMNA P02545 2/20 0.33
SLC15A2 Q16348 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL30721692 1.00 TDP1 (0.44) TDP1FFAR3ALDH1A1LCKFYN
Methacrylic Acid SCHEMBL1534331 1.00 TDP1 (0.44) TDP1FFAR3ALDH1A1LCKFYN
Methacrylic Acid SCHEMBL2581850 1.00
Methacrylic Acid SCHEMBL129271 1.00 TDP1 (0.44) TDP1FFAR3ALDH1A1LCKFYN
Methacrylic Acid SCHEMBL8340708 0.97 TDP1 (0.42) TDP1FFAR3ALDH1A1LCKFYN
Methacrylic Acid SCHEMBL28253327 0.94 TDP1 (0.40) TDP1FFAR3ALDH1A1LCKFYN
Methacrylic Acid SCHEMBL9142216 0.91 ALDH1A1 (0.39) TDP1FFAR3ALDH1A1LCKFYN
Methacrylic Acid SCHEMBL6696385 0.91 ALDH1A1 (0.46) TDP1FFAR3ALDH1A1LCKFYN
Methacrylic Acid SCHEMBL9625730 0.91 FFAR3 (0.42) TDP1FFAR3ALDH1A1LCKFYN
Methacrylic Acid SCHEMBL514763 0.91 ALDH1A1 (0.46) TDP1FFAR3ALDH1A1LCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230100363-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF ORCA HOLDINGS, LLC 2023-03-30 US claimed
US-20220177666-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF ORCA HOLDINGS, LLC 2022-06-09 US claimed
US-7678870-B2 Processable molecularly imprinted polymers THE JOHNS HOPKINS UNIVERSITY (US) 2010-03-16 US claimed
US-20070197746-A1 Processable molecularly imprinted polymers THE JOHNS HOPKINS UNIVERSITY 2007-08-23 US claimed
EP-1733211-A4 PROCESSABLE MOLECULARLY IMPRINTED POLYMERS UNIV JOHNS HOPKINS (US) 2007-05-30 EP claimed
EP-1733211-A1 PROCESSABLE MOLECULARLY IMPRINTED POLYMERS THE JOHNS-HOPKINS UNIVERSITY (US) 2006-12-20 EP claimed
WO-2005103655-A1 PROCESSABLE MOLECULARLY IMPRINTED POLYMERS THE JOHNS HOPKINS UNIVERSITY (US) 2005-11-03 WO claimed
EP-3479171-B1 PRINTABLE COMPOSITIONS INCLUDING HIGHLY VISCOUS COMPONENTS AND METHODS OF CREATING 3D ARTICLES THEREFROM SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2026-05-20 EP disclosed
US-12209172-B2 Curable compositions and methods of using the same 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-01-28 US disclosed
US-20240181430-A1 POROUS SORPTIVE SOLID PHASE MICROEXTRACTION DEVICES AND PREPARATION THEREOF MEMORIAL UNIVERSITY OF NEWFOUNDLAND (CA) 2024-06-06 US disclosed
US-11992538-B2 Polymerizable dental composition based on condensed silanes VOCO GMBH (DE) 2024-05-28 US disclosed
EP-3265049-B1 COMPOSITE MATERIAL HAVING CERAMIC FIBERS SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2024-05-01 EP disclosed
US-20230414458-A1 MULTI-PART DENTAL COMPOSITION HAVING STAGED VISCOSITY PRIOR TO HARDENING SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2023-12-28 US disclosed
EP-0259096-B1 DISINTEGRATION TYPE, CROSSLINKED ACRYLIC RESIN PARTICLES Nippon Paint Co., Ltd. (JP) 1992-05-06 EP disclosed
EP-0417606-A2 Method of making highly adsorptive copolymers DOW CORNING CORPORATION (US) 1991-03-20 EP disclosed
EP-0362855-A2 Core-shell polymer, composition containing the polymers and its molded articles Takeda Chemical Industries, Ltd. (JP) 1990-04-11 EP disclosed
EP-0259096-A1 Disintegration type, crosslinked acrylic resin particles Nippon Paint Co., Ltd. (JP) 1988-03-09 EP disclosed
EP-0256776-A2 Method of coating a substrate by electrodeposition Nippon Paint Co., Ltd. (JP) 1988-02-24 EP disclosed
EP-0033750-B1 CATALYST FOR PREPARING ARTIFICIAL DENTAL COMPOSITIONS OR DENTAL REPLACEMENT PARTS, ITS UTILISATION, AND ARTIFICIAL DENTAL COMPOSITIONS Etablissement Dentaire IVOCLAR (LI) 1983-11-30 EP disclosed
EP-0033750-A1 Catalyst for preparing artificial dental compositions or dental replacement parts, its utilisation, and artificial dental compositions Etablissement Dentaire IVOCLAR (LI) 1981-08-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230100363-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF CNR2, CNR1, CDIPT TDP1 3652/4885FFAR3 2967/4885ALDH1A1 3487/4885
US-11992538-B2 Polymerizable dental composition based on condensed silanes NCAPH, RCC1, NCAPD2 TDP1 2233/4885FFAR3 1374/4885ALDH1A1 1481/4885
US-12209172-B2 Curable compositions and methods of using the same MAT2B, MAT1A, MTR TDP1 1593/4885FFAR3 3526/4885ALDH1A1 194/4885
US-20220177666-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF CNR2, CNR1, CDIPT TDP1 3652/4885FFAR3 2967/4885ALDH1A1 3487/4885
US-20230414458-A1 MULTI-PART DENTAL COMPOSITION HAVING STAGED VISCOSITY PRIOR TO HARDENING POLR1A, POLR2A, POLR2H TDP1 446/4885FFAR3 490/4885ALDH1A1 1940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.